In utero alcohol effects on foetal, neonatal and childhood lung disease

Theresa W Gauthier1, Lou Ann S Brown1

  • 1Department of Paediatrics, Division of Neonatal-Perinatal Medicine, Emory University, 2015 Uppergate Dr. NE, Atlanta, GA 30322, USA.

Insights

Maternal alcohol use during pregnancy harms newborn lungs. New biomarkers and research are crucial to understand and address fetal alcohol exposure

Area of Science:

  • Neonatal research
  • Pulmonary medicine
  • Toxicology

Background:

  • Maternal alcohol consumption during pregnancy poses risks to newborns.
  • Fetal alcohol exposure negatively impacts lung development and immune function.
  • Identifying newborns exposed to alcohol in utero is challenging, limiting understanding of pulmonary effects.

Purpose of the Study:

  • To review advances in biomarkers for detecting in utero alcohol exposure.
  • To highlight the impact of alcohol toxicity on the developing fetal lung and immune system.
  • To present clinical evidence linking fetal alcohol exposure to adverse pulmonary outcomes in newborns.

Main Methods:

  • Review of current literature on fetal alcohol exposure and pulmonary health.
  • Analysis of biomarker development for in utero alcohol exposure.
  • Examination of clinical studies on the association between fetal alcohol exposure and respiratory conditions.

Main Results:

  • Fetal alcohol exposure adversely affects the developing lung and immune defense.
  • Biomarker development is advancing to identify exposed newborns.
  • Clinical evidence links fetal alcohol exposure to bronchopulmonary dysplasia, viral infections (e.g., RSV), and asthma/atopy.

Conclusions:

  • Accurate identification of alcohol-exposed offspring is essential.
  • Further research is needed to fully determine alcohol's impact on respiratory outcomes in children.
  • Understanding fetal alcohol's effects can lead to better prevention and management strategies for neonatal respiratory health.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.5K
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
4.1K